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Abstract 
Background: In Ghana, about 13 % of the adult population is estimated to be affected by mental health disorders 
of varying forms. In managing these patients, psychotropic medications are mostly employed. Since most of these 
conditions are chronic cases, the medications are consumed for prolonged periods of time. However, there exists an 
absence of information on efficacy, side effects, accessibility and prescription practices of psychotropic medication 
utilization from the viewpoint of the practitioners who are primarily involved in prescribing, dispensing and adminis-
tering these medications.
Method: Qualitative study composed of semi-structured interviews were conducted with twenty three (23) partici-
pants from Accra psychiatry, Pantang and Ankaful hospitals. These were fifteen (15) nurses, six (6) clinicians and two 
(2) pharmacists. All interviews were recorded digitally and analyzed thematically.
Results: The commonly prescribed psychotropic medications were grouped into four classes. These were antipsy-
chotics, antidepressants, anticonvulsants and hypnosedatives. Although each facility had at least one drug belong-
ing to each class, there were frequent shortages recorded across the board. Also, drugs were free when supplied by 
government, and expensive when obtained from outside. When subsidized, the average cost of a day’s supply of 
the most common antipsychotic was 4 % of the daily minimum wage. The procurement system for the medications 
was fraught with challenges such as inadequate financing, poor procurement practices and bureaucracies with the 
process which affected the availability and quality of medications.
Conclusion: The commonly prescribed psychotropic medications are in conformity with the recommendations of 
the WHO guidelines and the standard treatment guidelines of Ghana. However, the accessibility and quality of medi-
cations in the sector are inadequate. To improve mental health services in the country, it is important to ensure the 
adequate and regular provision of quality medicines in the mental health sector.
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Background
Worldwide, mental health disorders account for 14  % 
of the burden of diseases [1]. Similarly, the prevalence 
of mental health disorders in Ghana is 13 % of the adult 
population [2]. These disorders are of varying forms and 
may require numerous forms of care which could be 
either pharmacological or non-pharmacological [3, 4].
The mental health sector in Ghana hugely adopts the 
pharmacological method of managing mental illness 
due to the lack of personnel and resources for psychoso-
cial therapies and rehabilitation [2, 5, 6]. Primarily, this 
involves the use of medicines, suitably referred to as psy-
chotropic medications in sustaining patients. In Ghana, 
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Like other medications, psychotropic medications have 
undergone numerous phases of development which gen-
erally seek to improve upon the existing ones with regard 
to issues of efficacy, stability, side effects and specificity 
of actions. This has therefore accounted for the various 
generations of medications notably, the newer and older 
generations [7]. Ghana practices a hybrid system of com-
bining both generations, in an imbalanced fashion, favor-
ing the older generations because they are less expensive 
[8, 9]. These are the medications that have been impli-
cated in much notoriety and their usage expected to be 
on the decline [10].
Despite the widespread use of the older generation and 
gradual infiltration of the newer generation into the sys-
tem, less is known about the composite state of the medi-
cations especially from the viewpoint of the practitioners 
who are primarily involved in prescribing, dispensing and 
administering these medications. Issues regarding medi-
cations are often mentioned in studies that seek to exam-
ine other issues in the mental health sector bordering on 
policies, legislation and social framework of the sector 
[2, 5, 6, 8]. This current study therefore explored the psy-
chotropic medications used in Ghana from the perspec-
tive of the practitioners along the areas of efficacy, side 
effects, accessibility and prescription practices.
Methods
Study site
The study was conducted in the three public psychiatric 
hospitals in the country; Ankaful Hospital (AH), Pantang 
Hospital (PH) and the Accra Psychiatric Hospitals (APH). 
The AH was built in June 1965 and currently has a bed 
capacity of 500 to serve the inhabitants of the Central, 
Western and Ashanti Regions of Ghana. The AH serves 
about 7788 out-patients annually. It has 323 staff mem-
bers comprising 2 psychiatrists, 190 nurses, 1 occupa-
tional therapist, 1 psychologist and 129 other auxiliary 
staff. The PH manages patients with both physical and 
mental health conditions. Initially built with a 500 bed 
capacity, the hospital currently has 9 wards housing an 
average of 50 beds each. There is an average of 23,331 
annual out-patient psychiatry cases and a total of 1337 
in-patient cases. The hospital has 464 staff comprising 
nurses (316), pharmacists (1), psychiatrists (2), medical 
officers (1), psychologists (1), social workers (2), occu-
pational therapist (1) and other auxiliary staff (140). 
The APH is situated in Adabakra, in the Greater Accra 
Region. It comprises 21 wards housing 478 in-patients 
and records an average of 120 out-patient attendances. 
It has 451 staff members which comprises nurses (343), 
pharmacists (2), psychiatrists (4), medical officers (4), 
psychologist (1), social workers (4) and 108 other staff 
(http://www.thekintampoproject.org).
Participants
Participants for the study were selected based on conven-
ience sampling. Specifically, participants engaged were 
nurses, clinicians and pharmacists. Clinicians herein 
mentioned referred to psychiatrists, physicians and 
medical assistants. A total of 23 participants were sam-
pled for the study. This comprised fifteen nurses (5 from 
each hospital), six clinicians (2 from each hospital) and 
two pharmacists, one each from the Accra Psychiatric 
Hospital and Pantang Hospital. Prior to the commence-
ment of the main study, a pilot study was conducted. This 
was undertaken involving three nurses and two clinicians 
from the Accra Psychiatric Hospital. The pilot study was 
to aid in identifying the possible constraints of the study 
procedure as well as in developing appropriate question-
naires for the study.
Study tools
Based on available literature in the field and the aims of 
the study, an interview guide was developed. The inter-
views were semi-structured and each interview lasted 
an average of 30 min. Open ended questions were used 
to generate responses from the practitioners. Further 
probes and questions were used to illicit lucid responses 
and establish clarity.
Data management
All interviews were recorded using a digital audio 
recorder. The recordings were then transcribed verba-
tim and analysed with the aid of thematic analysis. The 
transcripts were carefully perused and manually coded 
to generate a coding frame. The codes were grouped into 
basic themes. The basic themes thus developed were 
merged into organizational themes or subthemes. A 
group of the subthemes were arched into global themes. 
These three themes were used in generating a thematic 
network which aided in the analysis [11]. Observa-
tions and other non-verbal discourses were recorded as 
memos in a notepad.
Ethics
Permission was obtained from the hospital authorities 
from the various institutions before the commencement 
of the study. All the participants gave informed written 
consent to participate in the study and to have the inter-
views recorded. Participants were assured of confidential-
ity in the analysis, processing, and presentation of results 
of the study. To ensure the information were anonymous 
and confidential, each participant was assigned an identi-
fication code which has been used in the presentation of 
the results. The participants are identified with their nar-
ratives using C, N, and P for clinicians, nurses and phar-
macists respectively.
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Results
Characteristics
The participants comprised clinicians (6), nurses (15) 
and pharmacists (2). Eleven out of the 23 participants 
interviewed were females with the majority (10) being 
nurses and one Clinician. Participants interviewed cut 
across the ranks of the various professions. The nurses 
included staff nurses (9), senior staff nurses (4) and nurs-
ing officers (1). There were 3 medical assistants, 2 physi-
cians and a psychiatrist. One of the pharmacists was of 
senior pharmacist rank and the other, a deputy director.
Themes
The analysis elicited the following themes: Common con-
ditions (Fig. 1), Common medications (Fig. 2), Side effects 
(Fig. 3), Drug administration practices (Fig. 4), Accessibil-
ity (Fig. 5) and Drug stability and efficacy (Fig. 6). The fig-
ures are diagrammatic representations of the main global, 
organizational basic themes. The basic themes are the 
textual concepts that were derived from the transcripts. 
They represented obvious thoughts, ideas or views that 
were expressed by the participants. The organizational 
themes arose from a cluster of basic themes and primar-
ily sought to organize basic themes with similar concepts 
into a much more defined group. The global theme was 
the encapsulating theme, taking into account the organi-
zational and basic themes which gave it a deeper mean-
ing. Distinctions amongst these 3 were created using 
defined colour codes.
Common conditions
The theme identified the various conditions presented at the 
psychiatric institutions. The common conditions presented 
varied across the wards since patients were admitted to spe-
cific wards based on presenting conditions. Two clinicians 
grouped psychiatric conditions into major and minor states. 
These classifications were based on the severity of presenta-
tion and the gravity of disturbance created within the indi-
vidual and to the environment. Psychosis, depression and 
other affective disorders formed the major disorders while 
the minor ones were composed of generalized anxiety dis-
order, mild depression and obsessive compulsive disorders;
We have the two major groups or types of mental ill-
ness which is the major mental illness, which is the psy-
chosis and the minor one which is neurosis…….(C1).
Besides these major groupings, there were a few other 
categorizations of the conditions; there were conditions 
referred to as the mood disorders which comprised hypo-
mania, mania and bipolar disorders. Also, numerous forms 
of psychosis were presented; drug induced psychosis, neu-
ropsychosis, undefined psychosis, post-partum psychosis 
and puerperal psychosis. Mental retardation or arrest of 
the mind was presented by two respondents as one of the 
conditions. Schizophrenia was the most mentioned con-
dition. Conditions such as substance abuse, delirium, and 
dementia also came up in the responses. Although men-
tioned as a common clinical condition, epilepsy was seen 
by two respondents to be out of place in psychiatry;
Normally it is said that epileptic cases should be 
seen by the general hospital but they have turned 
these patients to the mental hospital. (C1).
Common medications
Psychotropic medications were also known as psychoac-
tive medications in the responses. The commonly pre-
scribed medications were grouped into various categories 
often based on the conditions they were used to manage. 
Such groupings were common amongst the Clinicians and 
a few nurses while ten of the nurses gave a rough spread of 
medications when asked. The various groups of psycho-
tropic medicines given were antipsychotics, antidepres-
sant, anticonvulsants, anxiolytics and hypnosedatives.
Antipsychotics were said to be in two groups; the typi-
cal or first generation antipsychotics and then the atypi-
cal or second generation antipsychotics. Examples of the 
typical antipsychotics were given as chlorpromazine, 
haloperidol, trifluperazine and thioridazine. Olanzap-
ine, risperidone, clozapine were examples of the atypical 
antipsychotics. Chlorpromazine (CPZ), marketed under 
the brand largactil was seen as the commonest of the typ-
ical antipsychotics and still used in current practice;
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Here we use olanzapine, haloperidol and risperi-
done ….but the commonly used ones on the ward are 
these 3 medications. And then sorry, the almighty 
CPZ- largactil. (N8).
The atypical antipsychotics that emerged from the 
responses were olanzapine, clozapine, risperidone and 
quitiapine with olanzapine having the greatest frequency 
of use. Due to the minimal side effects of the atypical 
antipsychotics they served as better alternatives to the 
typical antipsychotics;
Initially that is what they were using but it has more 
side effects than the new ones just introduced… like 
the olanzapines and the risperdones have mild side 
effects. (N2).
Some respondents also referred to antidepressants as 
‘psychic energizers’. They included amitryptilline, setra-
line, fluoxetine, lithium, imipramine and citalopram. 
While the term ‘antiepileptic’ was used interchangeably 
with ‘anticonvulsants’ in most responses, respondents 
identified carbamazepine, sodium valproate, phenobarbi-
tone, phenytoin, topiramate and lamotrigine as the antie-
pileptic agents available.
Of these, carbamazepine (Tegretol®) and sodium val-
proate (Epilim®) had the highest frequencies. Besides 
being anticonvulsants they were noted as mood stabiliz-
ers by some of the respondents;
……and we also have carbamazepine, it is a mood 






























Fig. 2 Common medications N nurse, C clinician, P pharmacist          Global theme,  Organizational theme,     Basic theme,   Codes
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Diazepam and lorazepam were the commonly pre-
scribed anxiolytics which was also known as the minor 
tranquilizers.
Side effects
Respondents gave a myriad of side effects in relation to 
the consumption of the medications. Side effects to these 
medications were coded under antipsychotics, anticon-
vulsants and lithium. Antipsychotics were responsible for 
most of the side effects mentioned. Their side effects were 
grouped into extrapyramidal and metabolic side effects. 
The typical antipsychotics were noted for the extrapy-
ramidal side effects while the atypicals were responsible 
for the metabolic side effects. The extrapyramidal side 
effects included dystonia dyskinesia, drooling, occulo-
gyric crisis and twisting of neck while the metabolic dis-
orders were said to include diabetes and weight gain. A 
clinician summed these in the switch from the older to 
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We were running away from extrapyramidal side 
effect but then we ended up with metabolic issues. 
They could have dyslipidemia, changes in their cho-
lesterol, they could have diabetes because of prob-
lems with metabolism and sugars…….. And then the 
weight gain is a problem…..They may have amenor-
rhoea or dysmenorrhoea which may affect fertility. 
(C6).
Lithium carbonate was known to cause blood dyscra-
sia which was linked to its toxicity. Anticonvulsants were 
known to cause Steven Johnson’s syndrome and hypoen-
cephalus or spinal bifida as recounted by two clinicians.
The principal management method for these side 
effects was the concurrent administration of counterac-
tive drugs. These drugs were trihexyphenidyl (artane), 
benztropine and chlorpheniramine. Although rarely, a 
clinician reported switch of medications as a manage-
ment method for the side effects;
We take them off the medication; we stabilize them 
and move on to a safer drug. (C5).
Drug administration practices
This theme examined the various activities that are encom-
passed in drug administration. Emerging sub themes were 
the prescription pattern and drug monitoring.
The prescription pattern of the medications was ide-
ally the call of clinicians. Nevertheless, most nurses pro-
vided information on prescription patterns while others 
referred it to the appropriate professionals. Generally, 
the prescription pattern was informed by Drug factors, 
patient factors and disease factors. Drug factors influenc-
ing the prescription pattern were primarily availability, 
affordability, and accessibility and drug side effects.
Yea,..because anybody prescribing a drug, if you are 
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Fig. 5 Accessibility N nurse, C clinician, P pharmacist          Global theme,  Organizational theme,   Basic theme,   Codes
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sider the availability of the drug, accessibility and its 
affordability. These three things should go into con-
sideration…. (C1).
In Accra Psychiatric hospital, it was mentioned that 
daily bulletins of drugs in stock are issued from the phar-
macy to all clinicians to aid in decision making.
The patient factors that affected prescription pat-
terns were usually the diagnosis made through assess-
ment of patients. Daily assessments collated through 
nurses’ reports were sent to the clinicians for review 
and necessary actions were then taken. Although the 
lack of availability of assessment tools for diagnosis 
was mentioned, the mental state assessment (MSA) 
was the tool often used to aid in diagnosis of some 
mental illnesses.
Oh..clinical principles, you take a history, you 
examine, for us we do a mental state assessment 
and then based on those parameters you come by 
a diagnosis and then based on what the condition 
is you select a group of drugs or what the specific 
drug and appropriate for that condition. (C5).
In psychiatry we don’t have any test for people. It 
is just subjective. What the patient tells the doc-
tor, the doctor just uses the DSM manual to try 
and categorize it. We don’t have any laboratory 
test to confirm, in this part of the world. But in 
advanced countries they are doing it. (P2).
The majority of the respondents (21) admitted vari-
ous forms of either physical monitoring or laboratory 























Fig. 6 Drug stability and efficacy N nurse, C clinician, P pharmacist          Global theme,   Organizational theme,   Basic theme,   
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monitoring were undertaken. Physical monitoring 
included taking of vitals, the MSA and visual observa-
tions. These were regularly performed as reflected in the 
nurses’ responses.
Laboratory monitoring required the use of biochemical 
analysis (often blood) in measuring the levels and effects 
of some drugs in the body. It included the fasting blood 
sugar which was an indication for the diabetic effect of 
some drugs and the full blood count, which gave an indi-
cation of the blood cells depleting effects of some drugs.
It is only clozapine that I understand it depletes 
the white blood cells so we do full blood count every 
2 weeks before we put any patient on it. (C1).
Participants in all three institutions acknowledged the 
fact that these tests for monitoring were not routinely 
performed due to financial constraints and inadequate 
logistics.
…….the truth of the matter is, ideally in giving these 
drugs, all of the drugs we have our baseline data; full 
blood count, Liver function test, blood urea nitrogen 
& creatinine clearance to monitor the renal function. 
These are basic but in practicality the issue is we 
don’t do it all. We don’t. (C2).
Accessibility
The accessibility of the psychotropic medications was 
discussed along two major facets; the availability and 
affordability of the medications. With regard to avail-
ability, twenty-two respondents admitted the existence 
of shortages. To some, shortages were seen to be rife all 
year round while others acknowledged shortages as a 
seasonal occurrence. These shortages were in relation 
to the absence or infrequent supply of some common 
medications. In such cases, patients were either asked to 
purchase medications themselves, were switched to alter-
native medications or were completely starved of medi-
cations until a supply arrived.
Oh shortages! I will tell you it is a day to day battle. 
Today this is available tomorrow it is not. You can-
not say for sure that. There is no guarantee that you 
write a medication today and tomorrow it is avail-
able. (D5).
Reasons accounting for the shortages were directed 
at the office of the chief procurement officer of the psy-
chotropic medications. Most respondents were ignorant 
of the factors responsible for the shortages but surmised 
poor funding from the government could be respon-
sible for the shortages. The cumbersome nature of the 
procurement process for the drugs was also known to 
account for the shortages. The entire procurement pro-
cess was said to be bureaucratic and that resulted in 
delays in drug delivery for as long as 2 years.
It was generally acknowledged that mental health ser-
vices are free and as such patients do not pay for medi-
cations. In events of shortages, drugs became expensive 
when patients had to acquire from private pharmacies 
and relatively cheaper when bought from the pharmacies 
within the hospitals.
Drug stability and efficacy
With regard to stability, the study primarily probed into 
issues of expiry and the management of such drugs when 
encountered. A few respondents admitted to have come 
across expired drugs in their facilities either in recent 
times, or in the past.
We come across expired drugs…I called the atten-
tion of the in charge and he dealt with the expired 
drugs. (N10).
Two major sources of expired medications were iden-
tified. First, failure of clinicians to prescribe a particular 
drug resulted in hoarding over a period of time beyond 
their shelf life. Secondly, some drug donations obtained 
from donor agencies were said to often be products 
that were near expiry and when not consumed within 
a period, eventually got expired. Such products were 
discarded.
In assessing efficacy, the treatment outcomes and qual-
ity of medications were looked at. Treatment outcome 
herein is defined as the response of the patients to ther-
apy. Relapses were seen to be hugely common amongst 
patients. This response cut across institutions and profes-
sionals. The nature of the condition was partly respon-
sible for relapse. Thus, relapses were inherent in the 
definition of mental disorders.
Also relapses were noted to be dominant amongst non-
compliant patients who refused medications either as a 
result of lack of insight, side effects from medications or 
non-availability of medications;
So most of them they relapse especially due to non-
compliance of the drugs. (C3).
The issue of unavailability accounted for relapses 
amongst patients on the wards besides other factors 
such as lack of family support when discharges were 
due, infrequent reviews by clinicians and the switch of 
medications.
Some, as they are still on the ward they can relapse 
because they don’t have frequent reviews by their cli-
nicians. (N7).
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Discussion
Psychosis and schizophrenia were the common condi-
tions existing in all three institutions. Due to the similarity 
in the clinical presentations of either of these conditions, 
respondents were likely to interchange the use of the 
words except in few cases of informed Clinicians who 
sought to differentiate between the two. The frequency 
of the conditions presented differed slightly from official 
records [2]. This could have been partly due to the cap-
tioning of most conditions under one major category of 
disease other than the fragmentation observed in official 
records. The term ‘mood disorders’ was generally used to 
encapsulate the terms bipolar, manic or hypomania.
The common medications prescribed clearly gave 
an indication of the prevalent conditions in the system. 
Although not the most ideal, there still is a pronounced 
prescription of the typical antipsychotics. Such has 
been the situation for years now, giving reasons of cost 
and availability. They were relatively easily available and 
cheaper to obtain. These factors to an extent under-
mined issues of side effects produced by these medica-
tions when prescribing. Gradually, there is an infiltration 
of the newer generation antipsychotics which have much 
patient tolerability. It is likely that as patient preference 
for the atypical medications increases, there will be a cor-
responding shift in the prescription pattern.
Amitriptylline, sertraline and fluoxetine were the anti-
depressants mentioned. Accordingly, these are the only 
preparations indicated for the management of depression 
in Ghana [12].
Most of the side effects mentioned such as dystonia, roll-
ing of eyes and drooling of tongue are attributable to the 
typical antipsychotics. This called for regular co- prescrib-
ing of trihexyphenidyl to manage the side effects produced. 
It is necessary the long term economic and health viability 
of such practices be examined adequately to help inform 
stakeholders on the procurement of antipsychotics. The 
metabolic disorders produced by the newer generation med-
ications were not hugely pronounced, possibly due to the low 
frequency in prescribing and better patient tolerability.
Although at least one medication belonging to each 
therapeutic class of medication was available, shortages 
were rampant. Shortages could therefore be seen as an 
inadequate supply of the medications to patients, or the 
restriction of the available medications to a minority that 
could either afford or access through other privileges. 
Besides the inadequate funding from government (which 
solely funds the mental health sector), hitches in the pro-
curement system could have accounted for the shortages 
[13]. As such, the often available medications were the 
ones which were locally manufactured and less costly. By 
extension, local production of some of the medications is 
expedient in handling issues of shortages.
Prescribing of psychotropic medications bordered 
on professional competence. This was reflected in the 
varying depth of insights expressed by the various cli-
nicians with regard to the conditions and the medica-
tions. The use of the mental status assessment (MSA) is 
a recognized tool which aids in diagnosing mental illness. 
The MSA is a structured, in depth guideline in assess-
ing the mental state of an individual prior to diagnosis 
[14]. It focuses on observations made by Clinicians and 
responses inquired from individuals along certain core 
areas including appearance, speech, mood, thought, 
insight and attitude. This was not a much mentioned 
influence in prescribing possibly because irrespective 
of the diagnosis made the other factors had much influ-
ence on the prescription pattern. The availability and 
cost of the medications tied the Clinicians to very limited 
options. This has been responsible for a dominance of 
older generation drugs such as chlorpromazine and halo-
peridol in current practice. These are drugs which have 
pronounced sedative effects [15] and perhaps these seda-
tive effects were harnessed to calm patients.
The study acknowledges the following limitations. 
First, the sample contained only two pharmacists which 
is a reflection of the huge deficit of pharmacists working 
in the public psychiatric hospitals in Ghana. Given the 
important role of the pharmacist in providing informa-
tion on the actual dispensing of psychotropic medications 
in the psychiatric hospital, a larger number of pharma-
cists would have been appropriate. Second, although 
the study obtained information on the categories of pre-
scribed psychotropic medications, triangulation of facts 
on the quantities of medicines utilized could potentially 
enhance the data. The information could be obtained 
through the inclusion of less subjective sources such as 
a review of prescription records from patient charts, and 
pharmacy inventory reports over a period of time.
Conclusions
The study assessed the commonly prescribed psycho-
tropic medications in Ghana from the perspective of 
the practitioners. The commonly prescribed psycho-
tropic medications are in conformity with the recom-
mendations of the WHO guidelines and the standard 
treatment guidelines of the country. However, the 
accessibility and quality of medications are inadequate. 
This is partly attributable to insufficient funds to sup-
port the sector and technical challenges by stakeholders 
in assessing the medications. The availability of medi-
cations in the sector is also stifled by the procurement 
system for the drugs. To improve mental health services 
in the country, it is important to ensure the adequate 
and regular provision of quality medicines in the mental 
health sector.
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